{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T03:03:02Z","timestamp":1790218982863,"version":"4.1.0"},"reference-count":28,"publisher":"American Society for Microbiology","issue":"12","license":[{"start":{"date-parts":[[2004,12,1]],"date-time":"2004-12-01T00:00:00Z","timestamp":1101859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Infect Immun"],"published-print":{"date-parts":[[2004,12]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>\n            Tuberculosis is responsible for &gt;2 million deaths a year, and the number of new cases is rising worldwide. DNA vaccination combined with\n            <jats:italic>Mycobacterium bovis<\/jats:italic>\n            bacillus Calmette Gue\u0301rin (BCG) represents a potential strategy for prevention of this disease. Here, we used a heterologous prime-boost immunization approach using a combination of DNA plasmids and BCG in order to improve the efficacy of vaccination against\n            <jats:italic>Mycobacterium tuberculosis<\/jats:italic>\n            infection in mice. As model antigens, we selected the\n            <jats:italic>M. tuberculosis<\/jats:italic>\n            Apa (for alanine-proline-rich antigen) and the immunodominant Hsp65 and Hsp70 mycobacterial antigens combined with BCG. We demonstrated that animals injected with a combination of DNA vectors expressing these antigens, when boosted with BCG, showed increased specific antimycobacterial immune responses compared to animals vaccinated with BCG alone. More importantly, the protection achieved with this regimen was also significantly better than with BCG alone.\n          <\/jats:p>","DOI":"10.1128\/iai.72.12.6945-6950.2004","type":"journal-article","created":{"date-parts":[[2004,11,23]],"date-time":"2004-11-23T00:37:46Z","timestamp":1101170266000},"page":"6945-6950","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":70,"title":["A Heterologous DNA Priming-\n            <i>Mycobacterium bovis<\/i>\n            BCG Boosting Immunization Strategy Using Mycobacterial Hsp70, Hsp65, and Apa Antigens Improves Protection against Tuberculosis in Mice"],"prefix":"10.1128","volume":"72","author":[{"given":"Jose C.","family":"Ferraz","sequence":"first","affiliation":[{"name":"The National Institute for Medical Research, The Ridgeway, Mill Hill, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evangelos","family":"Stavropoulos","sequence":"additional","affiliation":[{"name":"The National Institute for Medical Research, The Ridgeway, Mill Hill, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Yang","sequence":"additional","affiliation":[{"name":"The National Institute for Medical Research, The Ridgeway, Mill Hill, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve","family":"Coade","sequence":"additional","affiliation":[{"name":"The National Institute for Medical Research, The Ridgeway, Mill Hill, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Espitia","sequence":"additional","affiliation":[{"name":"Departamento de Immunologi\u0301a, Instituto de Investigaciones Biome\u0301dicas, UNAM, Me\u0301xico-DF, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas B.","family":"Lowrie","sequence":"additional","affiliation":[{"name":"The National Institute for Medical Research, The Ridgeway, Mill Hill, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Joseph","family":"Colston","sequence":"additional","affiliation":[{"name":"The National Institute for Medical Research, The Ridgeway, Mill Hill, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo E.","family":"Tascon","sequence":"additional","affiliation":[{"name":"The National Institute for Medical Research, The Ridgeway, Mill Hill, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","first-page":"6549","volume":"70","year":"2000","unstructured":"Biet, F., L. Kremer, I. Wolowczuk, M. Delacre, and C. Locht. 2000. Mycobacterium bovis BCG producing interleukin-18 increases antigen-specific gamma interferon production in mice. Infect. Immun.70:6549-6557.","journal-title":"Infect. Immun."},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(02)00577-7"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.282.7.677"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.63.2.580-584.1995"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.69.6.4174-4176.2001"},{"key":"e_1_3_2_7_2","unstructured":"Ferraz C. Ph.D. thesis. University College London London United Kingdom. (Submitted.)"},{"key":"e_1_3_2_8_2","first-page":"1339","volume":"346","year":"2000","unstructured":"Fine, P. E. M. 2000. Variation in protection by BCG: implications of and for heterologous immunity. Lancet346:1339-1345.","journal-title":"Lancet"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.171.3.1602"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.2.6082.293"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.95.9.5299"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.274.45.32023"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.250480397"},{"key":"e_1_3_2_14_2","first-page":"6188","volume":"70","year":"2000","unstructured":"Jason, J., L. K. Archibald, O. C. Nwanyanwu, P. N. Kazembe, J. A. Chatt, E. Norton, H. Dobbie, and W. R. Jarvis. 2000. Clinical and immune impact of Mycobacterium bovis BCG vaccination scarring. Infect. Immun.70:6188-6195.","journal-title":"Infect. Immun."},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1038\/35095558"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.71.4.1929-1937.2003"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(97)00073-X"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.93.2.934"},{"key":"e_1_3_2_19_2","first-page":"115","volume":"3","year":"2001","unstructured":"Orme, I. M., D. N. McMurray, and J. T. Belisle. 2001. Tuberculosis vaccine development: recent progress. Trends Microbiol.3:115-118.","journal-title":"Trends Microbiol."},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(92)90794-4"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm859"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.169.6.3422"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780400212"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.61.2.742-750.1993"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.67.11.5567-5572.1999"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.71.9.4901-4907.2003"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm0896-888"},{"key":"e_1_3_2_28_2","doi-asserted-by":"crossref","unstructured":"Tascon R. E. M. J. Colston E. Stavropoulos S. Ragno D. Gregory and D. B. Lowrie. 1997. Protection against tuberculosis by plasmid DNA p. 181-185. In G. Gregoriadis B. McCormack and A. C. Allison (ed.) Vaccine design: the role of cytokine networks vol. 293. Kluwer Academic Publishers Hingham Mass.","DOI":"10.1007\/978-1-4899-0062-3_18"},{"key":"e_1_3_2_29_2","unstructured":"Infect. Immun."}],"container-title":["Infection and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/IAI.72.12.6945-6950.2004","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/IAI.72.12.6945-6950.2004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,5]],"date-time":"2022-03-05T04:32:43Z","timestamp":1646454763000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/IAI.72.12.6945-6950.2004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,12]]},"references-count":28,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2004,12]]}},"alternative-id":["10.1128\/IAI.72.12.6945-6950.2004"],"URL":"https:\/\/doi.org\/10.1128\/iai.72.12.6945-6950.2004","relation":{},"ISSN":["0019-9567","1098-5522"],"issn-type":[{"value":"0019-9567","type":"print"},{"value":"1098-5522","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,12]]},"assertion":[{"value":"2004-04-30","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2004-08-24","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2004-12-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}